Screening for lung cancer: No longer a taboo subject

Journal of Clinical Oncology

Volumn 20, Issue 8, 2002, Pages 1959-1961

  Jett, James R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; EDITORIAL; HUMAN; LUNG CANCER; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0037089591     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.8.1959     Document Type: Editorial

References (23)

1. Cancer statistics, 2002
2. American Cancer Society: Guidelines for the early detection of cancer
3. Screening for early lung cancer
4. Survival and mortality from lung cancer in a screened population
5. Lung cancer screening: The Mayo Program
6. The Mayo Lung Cohort: A regression analysis focusing on lung cancer incidence and mortality
7. Lung cancer mortality in the Mayo Lung Project: Impact on extended follow-up
8. Lung cancer detected during a screening program: Using four-month chest radiographs
9. Miss rate of lung cancer: On the chest radiograph in clinical practice
10. Results of three-year mass screening program for lung: Cancer using mobile low-dose spiral computed tomography scanner
11. Successful lung cancer screening with low-dose helical CT in addition to chest x-ray and sputum cytology: The comparison of two screening periods with or without helical CT
12. Early lung cancer action project: Overall design and findings from baseline screening
13. Screening for lung cancer with low-dose spiral computed tomography
14. Combination versus single agent chemo-therapy: Review of basis for selection of drug treatment of cancer
15. Clonal genetic alterations in lungs of current and former smokers
16. Molecular damage in the bronchial eptihelium of current and former smokers
17. Molecular detection of early lung cancer
18. Aberrant methylation of p16 INK4a: Is an early event in lung cancer and a potential biomarker for early diagnosis
19. Predicting first-line lung cancer by detecting aberrant promoter methylation in sputum
20. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
21. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: A prospect for early diagnosis
22. Human lung cancer antigens recognized by autologous antibodies: Definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3
23. Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries